CAST
Basic information
Region (hg38): 5:96247756-96779595
Links
Phenotypes
GenCC
Source:
- peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome (Strong), mode of inheritance: AR
- peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome (Moderate), mode of inheritance: AR
- peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome (Strong), mode of inheritance: AR
- peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome (Supportive), mode of inheritance: AR
- peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads (PLACK) | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 25683118 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAST gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 27 | ||||
missense | 44 | 58 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 5 | 2 | 9 | ||
non coding | 16 | 79 | 98 | |||
Total | 3 | 2 | 48 | 42 | 94 |
Highest pathogenic variant AF is 0.0000131
Variants in CAST
This is a list of pathogenic ClinVar variants found in the CAST region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-96390365-G-A | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96390367-C-T | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96390390-T-C | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96390419-T-C | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96390713-T-C | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jan 13, 2018) | ||
5-96390814-C-T | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96390835-G-A | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96390886-C-T | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96390982-T-C | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) | ||
5-96391034-G-A | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96391089-C-T | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jan 13, 2018) | ||
5-96391147-A-T | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) | ||
5-96391159-C-T | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jun 14, 2016) | ||
5-96391268-C-T | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) | ||
5-96391430-T-C | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jun 14, 2016) | ||
5-96391471-A-G | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Likely benign (Jun 14, 2016) | ||
5-96391558-G-A | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) | ||
5-96391587-T-G | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jan 13, 2018) | ||
5-96391600-G-A | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96391629-G-C | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 13, 2018) | ||
5-96391668-T-A | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) | ||
5-96391694-T-C | Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96391769-C-T | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jan 12, 2018) | ||
5-96391770-G-A | Obesity due to prohormone convertase I deficiency • Monogenic Non-Syndromic Obesity | Uncertain significance (Jan 12, 2018) | ||
5-96391837-A-G | Monogenic Non-Syndromic Obesity • Obesity due to prohormone convertase I deficiency | Uncertain significance (Jun 14, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAST | protein_coding | protein_coding | ENST00000395812 | 29 | 254329 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.12e-12 | 0.996 | 125691 | 0 | 57 | 125748 | 0.000227 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.384 | 402 | 381 | 1.06 | 0.0000192 | 4827 |
Missense in Polyphen | 141 | 140.13 | 1.0062 | 1991 | ||
Synonymous | 0.515 | 130 | 138 | 0.944 | 0.00000752 | 1434 |
Loss of Function | 2.74 | 26 | 46.1 | 0.564 | 0.00000195 | 665 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000315 | 0.000308 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000268 | 0.000264 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.000640 | 0.000588 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Specific inhibition of calpain (calcium-dependent cysteine protease). Plays a key role in postmortem tenderization of meat and have been proposed to be involved in muscle protein degradation in living tissue.;
- Disease
- DISEASE: Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads (PLACK) [MIM:616295]: An autosomal recessive disease characterized by generalized, continuous shedding of the outer layers of the epidermis, leukonychia, acral punctate keratosis, cheilitis, knuckle pads with multiple hyperkeratotic micropapules involving the interphalangeal joints, and palmoplantar keratoderma. {ECO:0000269|PubMed:25683118}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;mcalpain and friends in cell motility;Extracellular matrix organization;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.338
Intolerance Scores
- loftool
- 0.963
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.82
Haploinsufficiency Scores
- pHI
- 0.280
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.387
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.354
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cast
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- inhibition of cysteine-type endopeptidase activity;presynaptic active zone organization;negative regulation of type B pancreatic cell apoptotic process
- Cellular component
- endoplasmic reticulum;cytosol;membrane
- Molecular function
- protease binding;RNA binding;endopeptidase inhibitor activity;protein binding;calcium-dependent cysteine-type endopeptidase inhibitor activity;cadherin binding